Avicanna Inc.
AVCNF
Rank in Stocks
#28757
Avicanna Inc., a biopharmaceutical firm headquartered in Toronto, Canada, and... Avicanna Inc., a biopharmaceutical firm headquartered in Toronto, Canada, and founded in 2016, is actively engaged in the research, development, and commercialization of scientifically validated products for both global medical and consumer health markets. The company's comprehensive scientific framework encompasses R&D and clinical trials, often undertaken in collaboration with Canadian academic and medical institutions. This effort has yielded around twenty commercialized products spanning four primary market categories. These offerings include medical and wellness items under the RHO Phyto brand, featuring cannabinoids such as CBD, CBG, and THC; CBD-infused topical and derma-cosmetic products marketed under the Pura H&W and Pura Earth labels; and bulk cannabis and hemp-derived raw materials like dried flowers, standardized seeds, full-spectrum extracts, cannabinoid distillates, and isolates, provided through the Aureus brand. Additionally, Avicanna is advancing a pharmaceutical pipeline focused on treatments for conditions including epidermolysis bullosa, dermatological ailments, chronic pain, and various neurological disorders. A notable research partnership with Dr. Christine Allen's Research Group is dedicated to developing a cannabinoid-based therapy for lung inflammation linked to COVID-19.
Share Price
$0.07595
Last synced: 2026-11-09
Market Cap
$9.99M
Change (1 day)
1.27%
Change (1 year)
-59.79%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Avicanna Inc. (AVCNF)
Category
Healthcare
Operating Margin for Avicanna Inc. (AVCNF)
Operating Margin as of November 2026 TTM: -14.76%
According to Avicanna Inc.'s latest financial reports, its current operating margin (TTM) is -14.76%. At the end of 2025 the company had an operating margin of -10.66%.
Operating Margin history for Avicanna Inc. from 2016 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -14.76% | 38.46% |
| 2025 | -10.66% | -42.00% |
| 2024 | -18.38% | -61.10% |
| 2023 | -47.25% | -81.63% |
| 2022 | -257.16% | -26.34% |
| 2021 | -349.13% | -71.13% |
| 2020 | -1,209.43% | -91.24% |
| 2019 | -13,803.10% | 92.80% |
| 2018 | -7,159.39% | -26.17% |
| 2017 | -9,697.64% | 0.00% |
| 2016 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -101.32% |
DE
|
|
| 19.68% | -101.33% |
DE
|
|
| 13.26% | -100.90% |
JP
|
|
| 17.08% | -101.16% |
CH
|
|
| 14.92% | -101.01% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Avicanna Inc.'s operating margin
What is Avicanna Inc.'s operating margin?
Avicanna Inc.'s operating margin is -14.76%, as of Nov 2026.
What was Avicanna Inc.'s operating margin in 2025?
In 2025, Avicanna Inc.'s operating margin was -10.66%, compared with -18.38% in 2024.
How has Avicanna Inc.'s operating margin changed since 2020?
From 2020 to 2025, Avicanna Inc.'s operating margin was highest in 2025 (-10.66%) and lowest in 2020 (-1,209.43%).
How does Avicanna Inc.'s operating margin compare with similar companies?
Avicanna Inc.'s operating margin (-14.76%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.